Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cord Blood Stem Cell Transplantation | 6 | 2023 | 314 | 2.750 |
Why?
|
| Virus Diseases | 2 | 2022 | 711 | 1.020 |
Why?
|
| Metronidazole | 1 | 2019 | 217 | 0.620 |
Why?
|
| Histocompatibility Testing | 2 | 2023 | 741 | 0.620 |
Why?
|
| Adrenal Gland Diseases | 1 | 2019 | 138 | 0.610 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2022 | 1366 | 0.610 |
Why?
|
| Thrombocythemia, Essential | 1 | 2019 | 105 | 0.610 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 5445 | 0.610 |
Why?
|
| Infarction | 1 | 2019 | 244 | 0.600 |
Why?
|
| Polyneuropathies | 1 | 2018 | 137 | 0.580 |
Why?
|
| Primary Myelofibrosis | 1 | 2018 | 215 | 0.550 |
Why?
|
| Demyelinating Diseases | 1 | 2018 | 354 | 0.530 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 260 | 0.530 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 524 | 0.530 |
Why?
|
| Isoantibodies | 1 | 2018 | 679 | 0.490 |
Why?
|
| Hematologic Neoplasms | 2 | 2023 | 1832 | 0.480 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 1041 | 0.480 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 652 | 0.470 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 570 | 0.450 |
Why?
|
| Diarrhea | 1 | 2019 | 1348 | 0.410 |
Why?
|
| Lymphoma, B-Cell | 1 | 2018 | 931 | 0.400 |
Why?
|
| Brain Diseases | 1 | 2019 | 1558 | 0.350 |
Why?
|
| Alleles | 1 | 2020 | 6934 | 0.340 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 3175 | 0.310 |
Why?
|
| Graft Survival | 1 | 2018 | 3734 | 0.310 |
Why?
|
| Receptors, KIR | 2 | 2022 | 113 | 0.250 |
Why?
|
| Cyclophosphamide | 2 | 2023 | 2241 | 0.250 |
Why?
|
| Busulfan | 1 | 2023 | 263 | 0.210 |
Why?
|
| Vidarabine | 1 | 2023 | 345 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7172 | 0.200 |
Why?
|
| Cytapheresis | 1 | 2019 | 8 | 0.180 |
Why?
|
| Mycobacteriaceae | 1 | 2019 | 4 | 0.180 |
Why?
|
| Graft vs Host Disease | 2 | 2023 | 2958 | 0.180 |
Why?
|
| Burkitt Lymphoma | 1 | 2022 | 326 | 0.180 |
Why?
|
| Actinomycetales Infections | 1 | 2019 | 30 | 0.170 |
Why?
|
| Ligands | 2 | 2022 | 3281 | 0.160 |
Why?
|
| Granulocytes | 1 | 2019 | 548 | 0.150 |
Why?
|
| Soft Tissue Infections | 1 | 2019 | 155 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11524 | 0.150 |
Why?
|
| Hydroxyurea | 1 | 2019 | 289 | 0.150 |
Why?
|
| Neural Conduction | 1 | 2018 | 441 | 0.150 |
Why?
|
| Drug Monitoring | 1 | 2023 | 953 | 0.140 |
Why?
|
| HLA Antigens | 1 | 2022 | 1382 | 0.140 |
Why?
|
| Vincristine | 1 | 2018 | 1039 | 0.140 |
Why?
|
| Adrenal Glands | 1 | 2019 | 547 | 0.140 |
Why?
|
| Transplantation Conditioning | 1 | 2023 | 1599 | 0.140 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2018 | 693 | 0.130 |
Why?
|
| Prednisone | 1 | 2018 | 1574 | 0.110 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1520 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2019 | 2226 | 0.110 |
Why?
|
| Recurrence | 2 | 2022 | 8337 | 0.110 |
Why?
|
| Doxorubicin | 1 | 2018 | 2234 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2019 | 1367 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9239 | 0.080 |
Why?
|
| Humans | 13 | 2023 | 743811 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12243 | 0.070 |
Why?
|
| Aspirin | 1 | 2019 | 3283 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 3524 | 0.070 |
Why?
|
| Thrombosis | 1 | 2019 | 2968 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9139 | 0.060 |
Why?
|
| Risk Factors | 2 | 2022 | 72252 | 0.060 |
Why?
|
| Aged | 4 | 2020 | 163178 | 0.060 |
Why?
|
| Male | 6 | 2020 | 349776 | 0.060 |
Why?
|
| Incidence | 1 | 2020 | 20948 | 0.050 |
Why?
|
| Middle Aged | 4 | 2020 | 213241 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2022 | 343 | 0.040 |
Why?
|
| Ovulation Induction | 1 | 2022 | 274 | 0.040 |
Why?
|
| Antibodies, Bispecific | 1 | 2022 | 164 | 0.040 |
Why?
|
| Amikacin | 1 | 2019 | 48 | 0.040 |
Why?
|
| Leukapheresis | 1 | 2019 | 131 | 0.040 |
Why?
|
| Female | 5 | 2022 | 380020 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29052 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2019 | 2253 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 213889 | 0.040 |
Why?
|
| Debridement | 1 | 2019 | 492 | 0.040 |
Why?
|
| Epitopes | 1 | 2023 | 2570 | 0.030 |
Why?
|
| Fingers | 1 | 2019 | 513 | 0.030 |
Why?
|
| Methotrexate | 1 | 2022 | 1726 | 0.030 |
Why?
|
| Cell Count | 1 | 2019 | 1855 | 0.030 |
Why?
|
| Japan | 1 | 2019 | 1360 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 56392 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 63042 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 26345 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5078 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 35409 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 3718 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77410 | 0.010 |
Why?
|
Concepts
(87)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_